Peginterferon alfa-2a Interactions
There are 229 drugs known to interact with peginterferon alfa-2a, along with 10 disease interactions. Of the total drug interactions, 40 are major, 184 are moderate, and 5 are minor.
- View all 229 medications that may interact with peginterferon alfa-2a
- View peginterferon alfa-2a disease interactions (10)
Most frequently checked interactions
View interaction reports for peginterferon alfa-2a and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Acidophilus (lactobacillus acidophilus)
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Allegra (fexofenadine)
- Amoxil (amoxicillin)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Augmentin (amoxicillin / clavulanate)
- Azstarys (dexmethylphenidate / serdexmethylphenidate)
- B Complex 50 (multivitamin)
- Benadryl (diphenhydramine)
- Celebrex (celecoxib)
- Celexa (citalopram)
- CellCept (mycophenolate mofetil)
- Centrum (multivitamin with minerals)
- Incivek (telaprevir)
- Klonopin (clonazepam)
- Lamictal (lamotrigine)
- Lexapro (escitalopram)
- Lithium Carbonate ER (lithium)
- Nexium (esomeprazole)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- RibaPak (ribavirin)
- Topamax (topiramate)
- Vitamin B1 (thiamine)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Peginterferon alfa-2a disease interactions
There are 10 disease interactions with peginterferon alfa-2a which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- autoimmune hepatitis
- depression
- severe hepatic disease
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pulmonary disorders
Report options
More about peginterferon alfa-2a
- peginterferon alfa-2a consumer information
- Compare alternatives
- Reviews (19)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral interferons
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Vemlidy
Vemlidy (tenofovir alafenamide) is an oral, once-daily, antiviral tablet that may be used to treat ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Viread
Viread (tenofovir) is used to treat HIV, which causes the acquired immunodeficiency syndrome ...
Baraclude
Baraclude (entecavir) is and antiviral medicine used to treat chronic hepatitis B. Includes ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.